Published in Br Med J on July 03, 1965
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Use of pulsed-field gel electrophoresis for epidemiological study of Bordetella pertussis in a whooping cough outbreak. J Clin Microbiol (1994) 4.13
Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants. Br Med J (1969) 3.69
Reactions after pertussis vaccine: a manufacturer's experiences and difficulties since 1964. Br Med J (1978) 2.54
Efficacy of pertussis vaccines: a brighter horizon. Br Med J (1972) 2.04
Prevalent serotypes of Bordetella pertussis in non-vaccinated communities. J Hyg (Lond) (1976) 1.57
Attack rates of notified whooping cough in immunised and unimmunised children. Br Med J (1976) 1.52
Mouse-protective properties of Bordetella pertussis serotypes in passive tests. J Bacteriol (1967) 1.34
Diagnosis of whooping cough: comparison of serological tests with isolation of Bordetella pertussis. A combined Scottish study. Br Med J (1970) 1.31
Bordetella pertussis serotypes in the United States. Appl Microbiol (1969) 1.29
Bordetella pertussis culture having only species factor 1. J Bacteriol (1966) 1.18
Pertussis: challenges today and for the future. PLoS Pathog (2013) 1.15
Trimethoprim-sulphamethoxazole in pertussis: comparison with tetracycline. Arch Dis Child (1972) 1.14
The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period. J Hyg (Lond) (1976) 1.12
The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci (2016) 0.91
Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proc Natl Acad Sci U S A (2015) 0.88
Bordetella pertussis serotypes in Canada. Can Med Assoc J (1978) 0.88
Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s. J Bacteriol (1966) 0.85
Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis. BMC Immunol (2015) 0.79
Infectious diseases as a specialty. Br Med J (1967) 0.75
Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination. Epidemics (2016) 0.75
Immunization practice in the United Sttes and Great Britain: a comparative study. Postgrad Med J (1969) 0.75
Variation of killing power of human sera against Bordetella pertussis. Clin Exp Immunol (1969) 0.75
Immunization against whooping-cough. Br Med J (1969) 0.75
TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH. Br Med J (1963) 6.83
The relation between agglutinin production by pertussis vaccines and their immunising potency in mice. J Pathol Bacteriol (1959) 4.21
TYPE-SPECIFIC IMMUNITY AGAINST WHOOPING-COUGH. Br Med J (1963) 6.83
The relation between agglutinin production by pertussis vaccines and their immunising potency in mice. J Pathol Bacteriol (1959) 4.21
The influence of oxygen and arginine on the motility of a strain of Pseudomonas sp. J Gen Microbiol (1957) 4.09
Type-specific immunity against intracerebral pertussis infection in mice. Nature (1963) 2.85
Reproducible results with the Gram stain. J Pathol Bacteriol (1962) 2.03
The influence of temperature on the motility of Pasteurella pseudotuberculosis. J Gen Microbiol (1952) 1.00
Factors influencing the assay of the histamine-sensitising factor of Haemophilus pertussis. J Pathol Bacteriol (1959) 0.86
Spirillum mancuniense n. sp. J Gen Microbiol (1955) 0.77
Intratracheal infection of mice with Haemophilus pertussis. J Pathol Bacteriol (1958) 0.75